Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Category: NIAID

Posted on May 24, 2020

Remdesivir trial results: NEJM, NIAID and Gilead provide conflicting information

Information shared by the three stakeholders — NEJM, NIAID and Gilead — on critical issues about whether the drug’s ability to reduce mortality is statistically significant and which category of…

Continue Reading
Posted on May 18, 2020May 19, 2020

Moderna’s coronavirus vaccine is safe, interim results of phase-1 trial shows

Interim results of Moderna’s phase-1 human clinical trial of novel coronavirus vaccine (mRNA-1273) shows the vaccine is safe. The vaccine was also able to elicit neutralizing antibodies. Interim results of…

Continue Reading
Posted on April 7, 2020April 10, 2020

Hydroxychloroquine study: Publisher expresses ‘concerns’ about the paper

The journal that published a paper claiming that hydroxychloroquine had “significant” success in treating COVID-19 patients now has an expression of “concerns” published by its publisher. On March 23, ICMR…

Continue Reading
Posted on March 24, 2020March 24, 2020

COVID-19: Doctors cautious over use of malaria drug as prophylaxis

Based on weak evidence, ICMR has recommended hydroxychloroquine as prophylaxis by healthcare workers taking care of COVID-19 cases and asymptomatic household contacts of confirmed cases. No other drug approving agency…

Continue Reading
Posted on April 15, 2016June 28, 2016

A ‘turning point’ in the Zika outbreak

More than 50 years after the infectious pathogen, rubella virus, was identified as the cause of an epidemic of congenital defects, the Centres for Disease Control and Prevention (CDC) in…

Continue Reading
Posted on January 6, 2016

H1N1 vaccine trial in pregnant women set to begin soon in the U.S.

Published in The Hindu on September 10, 2009 The world’s first clinical trial of H1N1 influenza vaccine in pregnant women will be launched this week in the U.S. Pregnant women…

Continue Reading
Posted on January 5, 2016

Single dose of H1N1 vaccine produces robust immune response

Published in The Hindu on September 12, 2009 The safety of 2009 influenza A(H1N1) vaccines that are undergoing clinical trials in different countries has got a shot in the arm.…

Continue Reading
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,581 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • Indian scientists divided over restricted use approval for Covaxin January 15, 2021
  • Vaccine dilemma: To take or not to take Covaxin January 15, 2021
  • Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial January 13, 2021
  • New challenges in conducting COVID-19 vaccine trials in India January 9, 2021
  • I would not take Covaxin without efficacy data: Gagandeep Kang January 8, 2021

Most Read Posts

  • Examination without invigilation - An experiment in trust
  • Vaccine dilemma: To take or not to take Covaxin
  • 'Serum’s pneumococcal vaccine will be available by June 2020'
  • Sadhguru Jaggi Vasudev, stop spreading vaccine misinformation
  • India's TB control programme renamed to reflect its intent on ending TB
  • UGC removes 4,305 journals from White list, including the Lancet Public Health
  • I would not take Covaxin without efficacy data: Gagandeep Kang
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,581 other followers

Archives

Cancel